Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India”
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Letter to editor – observation on the article titled “Vaccine-Induced Thrombotic Thrombocytopenia (VITT): first report from India” ; volume:21 ; number:1 ; day:24 ; month:4 ; year:2023 ; pages:1-2 ; date:12.2023
Thrombosis journal ; 21, Heft 1 (24.4.2023), 1-2, 12.2023
- Creator
-
Kotwal, Jyoti
Balraam, K. V. Vinu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12959-023-00470-x
- URN
-
urn:nbn:de:101:1-2023090209264058172249
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kotwal, Jyoti
- Balraam, K. V. Vinu
- SpringerLink (Online service)
Other Objects (12)
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear
Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT
Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear
Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT
Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis
Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT)
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase Inhibitors
Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear
Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia
Sinopharm (HB02)-associated vaccine-induced immune thrombotic thrombocytopenia: a case report
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT
Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis